Squeeze Setup
Inovio Pharmaceuticals (INO) has emerged as the top candidate for a potential short squeeze, according to the latest market data. With a squeeze score of 92.8, the stock is seeing significant bearish pressure, evidenced by 22.2% of its float currently sold short. The borrow fee for the stock stands at 22.1%, indicating that shares are becoming increasingly expensive and difficult to source for short sellers.
Market Data
While short interest figures are based on the bi-monthly FINRA settlement schedule, the high squeeze score and elevated borrow fees suggest that the bearish sentiment remains intense. The days-to-cover ratio is currently 0.8, implying that short sellers could be forced to cover their positions rapidly if a price catalyst triggers a move upward.
Key Takeaways
- INO holds the #1 spot on the short squeeze leaderboard with a score of 92.8.
- Short interest accounts for 22.2% of the total float.
- Borrow fees are elevated at 22.1% APR, signaling a tight lending market.
- Low days-to-cover ratio suggests potential for rapid volatility.
The Bottom Line
INO is currently the most crowded short trade on the board, making it a primary focus for traders looking for potential squeeze setups.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.